HT
FLNA

Headlands Technologies’s Filana Therapeutics FLNA Stock Holding History

Headlands Technologies’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,866
Closed -$101K – 938
2025
Q4 		$101K Buy
50,866
+25,583
+101% +$81.9K 0.01% 628
2025
Q3 		$73.6K Buy
+25,283
New +$58.1K 0.01% 582
2024
Q4 		– Sell
-20,303
Closed -$598K – 1528
2024
Q3 		$598K Buy
+20,303
New +$468K 0.07% 307
2023
Q4 		– Sell
-2,173
Closed -$36.2K – 1248
2023
Q3 		$36.2K Buy
2,173
+2,164
+24,044% +$42.9K 0.02% 494
2023
Q2 		$221 Buy
+9
New +$217 ﹤0.01% 767

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Headlands Technologies's FLNA Position: Q1 2026 in Review

Headlands Technologies sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 50,866 shares — an estimated $101K sold.

Headlands Technologies first reported a position in FLNA in Q2 2023 and held it in 5 quarters. The position peaked at $598K in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Headlands Technologies reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 50,866 Filana Therapeutics shares in Q1 2026, an estimated $101K.
  • Headlands Technologies first reported a position in Filana Therapeutics in Q2 2023 and held it in 5 quarters.
  • Headlands Technologies's Filana Therapeutics position peaked at $598K in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.